Irvine, CA – November 13, 2025 – Sayenza Biosciences is thrilled to announce the appointment of Randy B. Miller, MD to its Clinical Advisory Board. Dr. Miller is a renowned cosmetic and reconstructive plastic surgeon and a pioneer in regenerative medicine, bringing over 25 years of clinical experience to the Sayenza team. In this advisory role, Dr. Miller will provide strategic guidance on the development and clinical adoption of Sayenza’s cutting-edge adipose tissue processing platform.
Dr. Miller is internationally recognized for his work in stem cell research and therapy, including innovations in using fat-derived stem cells for healing and regeneration. He has served as President of the Florida Society of Plastic Surgeons and the Miami Society of Plastic Surgeons, among other leadership roles, and is a co-founder of the American College of Regenerative Medicine – the first interdisciplinary society dedicated to advancing stem cell and regenerative medicine. As a clinical professor of plastic surgery at the University of Miami, Dr. Miller has mentored countless surgeons and contributed extensively to the field of aesthetic and reconstructive surgery.
“We are excited and honored to welcome Dr. Randy Miller to our Advisory Board,” said Derek A. Banyard, MD, MS, MBA, co-founder and CEO of Sayenza Biosciences. “Dr. Miller’s expertise in plastic and regenerative surgery is unparalleled. His guidance will be invaluable as we advance our mission to democratize regenerative medicine using fat – the body’s largest source of stem cells. Having a thought leader of his caliber on our team validates our technology and will help accelerate its clinical adoption by surgeons worldwide.”
Dr. Miller shared his enthusiasm about joining Sayenza Biosciences: “I am thrilled to join the advisory board of Sayenza Biosciences. This company is at the forefront of a major shift in regenerative medicine. In my practice, I’ve seen the tremendous potential of adipose-derived stem cell therapies. Sayenza’s innovative platform takes that potential to the next level by making fat-based regenerative treatments faster and more accessible. I look forward to working with the team to bring this breakthrough to more physicians and patients.”
The addition of Dr. Miller to the Clinical Advisory Board comes as Sayenza Biosciences continues to make strides in developing its automated fat processing technology. With Dr. Miller’s clinical insight and leadership, the company aims to accelerate product development and refine its approach to meet the needs of both surgeons and patients. His involvement will help ensure that Sayenza’s solutions are effectively integrated into surgical practice and deliver impactful results in aesthetic and reconstructive procedures.
